Variant report
Variant | nsv587753 |
---|---|
Chromosome Location | chr21:45681822-45683121 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:7)
- CpG islands (count:61)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:7 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | EGR1 | chr21:45681580-45681947 | K562 | blood: | n/a | n/a |
2 | EGR1 | chr21:45681705-45681972 | K562 | blood: | n/a | n/a |
3 | ELF1 | chr21:45683096-45683404 | GM12878 | blood: | n/a | chr21:45683380-45683392 |
4 | THAP1 | chr21:45681580-45681822 | K562 | blood: | n/a | n/a |
5 | ZBTB7A | chr21:45683090-45683659 | K562 | blood: | n/a | n/a |
6 | ZBTB7A | chr21:45683093-45683338 | K562 | blood: | n/a | n/a |
7 | ZBTB7A | chr21:45681814-45681932 | K562 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr21:45681834-45681884 | A549 | lung: | n/a |
2 | chr21:45681834-45681884 | ECC-1 | luminal epithelium: | n/a |
3 | chr21:45681834-45681884 | HEK293 | kidney: | embryo |
4 | chr21:45681834-45681884 | HRPEpiC | eye: | n/a |
5 | chr21:45681834-45681884 | SK-N-SH_RA | brain: | n/a |
6 | chr21:45681834-45681884 | LNCaP | prostate: | n/a |
7 | chr21:45681834-45681884 | HEEpiC | esophagus: | n/a |
8 | chr21:45681834-45681884 | HL-60 | blood: | n/a |
9 | chr21:45681834-45681884 | GM06990 | blood: | n/a |
10 | chr21:45681834-45681884 | CMK | blood: | n/a |
11 | chr21:45681834-45681884 | PANC-1 | pancreas: | n/a |
12 | chr21:45681834-45681884 | AG09319 | gingival: | n/a |
13 | chr21:45681834-45681884 | H1-hESC | embryonic stem cell: | embryo |
14 | chr21:45681834-45681884 | NH-A | brain: | n/a |
15 | chr21:45681834-45681884 | NHBE | bronchial: | n/a |
16 | chr21:45681834-45681884 | U87 | brain: | n/a |
17 | chr21:45681834-45681884 | HCT-116 | colon: | n/a |
18 | chr21:45681834-45681884 | HUVEC | blood vessel: | n/a |
19 | chr21:45681834-45681884 | Hela-S3 | cervix: | n/a |
20 | chr21:45681834-45681884 | GM19239 | blood: | n/a |
21 | chr21:45681834-45681884 | HRCEpiC | kidney: | n/a |
22 | chr21:45681834-45681884 | IMR90 | lung: | fetal |
23 | chr21:45681834-45681884 | SK-N-SH | brain: | n/a |
24 | chr21:45681834-45681884 | RPTEC | kidney: | n/a |
25 | chr21:45681834-45681884 | BE2_C | brain: | n/a |
26 | chr21:45681834-45681884 | Hepatocyte | liver: | n/a |
27 | chr21:45681834-45681884 | AG04450 | lung: | fetal |
28 | chr21:45681834-45681884 | MCF10A-Er-Src | breast: | n/a |
29 | chr21:45681834-45681884 | BJ | skin: | n/a |
30 | chr21:45681834-45681884 | HMEC | breast: | n/a |
31 | chr21:45681834-45681884 | NHDF-neo | bronchial: | n/a |
32 | chr21:45681834-45681884 | SAEC | small airway: | n/a |
33 | chr21:45681834-45681884 | NB4 | blood: | n/a |
34 | chr21:45681834-45681884 | MCF-7 | breast: | n/a |
35 | chr21:45681834-45681884 | SKMC | muscle: | n/a |
36 | chr21:45681834-45681884 | GM12891 | blood: | n/a |
37 | chr21:45681834-45681884 | HRE | kidney: | n/a |
38 | chr21:45681834-45681884 | HAEpiC | amniotic membrane: | n/a |
39 | chr21:45681834-45681884 | NT2-D1 | testis: | n/a |
40 | chr21:45681834-45681884 | Jurkat | blood: | n/a |
41 | chr21:45681834-45681884 | HPAEpiC | pulmonary alveolar: | n/a |
42 | chr21:45681834-45681884 | AG09309 | skin: | n/a |
43 | chr21:45681834-45681884 | HepG2 | liver: | n/a |
44 | chr21:45681834-45681884 | K562 | blood: | n/a |
45 | chr21:45681834-45681884 | GM12892 | blood: | n/a |
46 | chr21:45681834-45681884 | AoSMC | blood vessel: | n/a |
47 | chr21:45681834-45681884 | ProgFib | skin: | n/a |
48 | chr21:45681834-45681884 | PrEC | prostate: | n/a |
49 | chr21:45681834-45681884 | AG10803 | skin: | n/a |
50 | chr21:45681834-45681884 | HCPEpiC | choroid plexus: | n/a |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr21:45680895..45685107-chr21:45717932..45721130,4 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
DNMT3L | TF binding region |
DNMT3L | CpG island |
ENSG00000141959 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs556893816 | chr21:45681827-45681828 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs181641804 | chr21:45681852-45681853 | Weak transcription Enhancers | TF binding regionCpG islandChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs542166466 | chr21:45681877-45681878 | Weak transcription Enhancers | TF binding regionCpG islandChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs113185110 | chr21:45681878-45681879 | Weak transcription Enhancers | TF binding regionCpG islandChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs62226881 | chr21:45681887-45681888 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs560389133 | chr21:45681907-45681908 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs113544693 | chr21:45681981-45681982 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs572477758 | chr21:45682048-45682049 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs112542439 | chr21:45682049-45682050 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs59593850 | chr21:45682081-45682082 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs59446093 | chr21:45682166-45682167 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs57918171 | chr21:45682167-45682168 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs543123444 | chr21:45682397-45682398 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs540055550 | chr21:45682403-45682404 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs147895125 | chr21:45682475-45682476 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs564774130 | chr21:45682507-45682508 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs532152284 | chr21:45682520-45682521 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs561740650 | chr21:45682525-45682526 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs56988500 | chr21:45682538-45682539 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs60296086 | chr21:45682544-45682545 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs141656595 | chr21:45682545-45682546 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs560497453 | chr21:45682568-45682569 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs548121635 | chr21:45682569-45682570 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs192493044 | chr21:45682570-45682571 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs377216357 | chr21:45682589-45682590 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs533837455 | chr21:45682593-45682594 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs180821595 | chr21:45682594-45682595 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs571106634 | chr21:45682628-45682629 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs116458620 | chr21:45682652-45682653 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs556588549 | chr21:45682711-45682712 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs145505737 | chr21:45682785-45682786 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs575033277 | chr21:45682791-45682792 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs147731811 | chr21:45682803-45682804 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs149216252 | chr21:45682807-45682808 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs572335716 | chr21:45682813-45682814 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs545919973 | chr21:45682870-45682871 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs3838124 | chr21:45682877-45682878 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs564235799 | chr21:45682878-45682879 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs576665048 | chr21:45682929-45682930 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs370596684 | chr21:45682939-45682940 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs185901491 | chr21:45682970-45682971 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs189939963 | chr21:45682971-45682972 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs529972395 | chr21:45683022-45683023 | Weak transcription Enhancers Transcr. at gene 5' and 3' | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs116495155 | chr21:45683092-45683093 | Weak transcription Enhancers Transcr. at gene 5' and 3' | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs182552297 | chr21:45683100-45683101 | Weak transcription Enhancers Transcr. at gene 5' and 3' | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs527280916 | chr21:45683112-45683113 | Weak transcription Enhancers Transcr. at gene 5' and 3' | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Down syndrome | 17412756 | CNVD |
Down syndrome | 17576883 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Seminomas | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 19156837 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Melanoma | 18172304 | CNVD |
Autism | 22958593 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Wilms tumour | 21544195 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Mental retardation | 21031080 | CNVD |
Polymicrogyria | 21031080 | CNVD |
periventricular nodular heterotopia | 21031080 | CNVD |
Myelodysplastic syndrome | 21606161 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Autism | 18414403 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Breast cancer | 21858162 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 17899364 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 20473283 | CNVD |
Chordoma | 18071362 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-syndromic sensorineural hearing loss | 17457615 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 23341502 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Cholangiocarcinoma | 16830362 | CNVD |
Down syndrome | 17334655 | CNVD |
Neuroticism | 17667963 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Autoimmune polyendocrine syndrome | 18200029 | CNVD |
Prostate cancer | 19363497 | CNVD |
Lung cancer | 17086460 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Multiple myeloma | 16616336 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21509527 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 17142309 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
small cell lung cancer | 17426248 | CNVD |
Ependymoma | 20639864 | CNVD |
Breast cancer | 21364760 | CNVD |
Down syndrome | 21154855 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr21:45662800-45705600 | Weak transcription | Right Atrium | heart |
2 | chr21:45681000-45682600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr21:45681400-45682000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr21:45681600-45683000 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
5 | chr21:45681800-45683000 | Weak transcription | H1 Cell Line | embryonic stem cell |
6 | chr21:45681800-45683000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
7 | chr21:45681800-45683200 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
8 | chr21:45682000-45682400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr21:45682400-45683800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
10 | chr21:45682600-45683000 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr21:45682600-45684600 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
12 | chr21:45682800-45684000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr21:45683000-45683200 | Transcr. at gene 5' and 3' | iPS DF 19.11 Cell Line | embryonic stem cell |
14 | chr21:45683000-45683400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
15 | chr21:45683000-45683600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
16 | chr21:45683000-45683600 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
17 | chr21:45683000-45683800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
18 | chr21:45683000-45683800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
19 | chr21:45683000-45683800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
20 | chr21:45683000-45684000 | Enhancers | H1 Cell Line | embryonic stem cell |
21 | chr21:45683000-45684000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
22 | chr21:45683000-45684000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
23 | chr21:45683000-45684200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |